China Pharma  Inc. logo

China Pharma Inc.

CPHI | AMEX
Chart Builder DCF Calculator
$0.69
-$0.02 (-2.82%)
At close: Sep 21, 2026, 3:59 PM ET
$0.72
+$0.03 (+4.30%)
Pre-market: Sep 22, 2026, 8:57 AM ET

Market Data

Market Cap
$27.62M
Enterprise Value
$-156.49B
Beta
1.05
Average Volume
4.44M
Shares Outstanding (Diluted)
40.52M
Shares Change YoY
1142.24%
Institutional Ownership
0.60%
Exchange
AMEX
ISIN
US16941T4013

Price Performance

Price Change 1M
-31.0%
Price Change 3M
-0.7%
Price Change 6M
7.8%
Price Change YTD
-43.0%
Price Change 1Y
-65.0%
Price Change 3Y
-90.1%
Price Change 5Y
-99.8%
1M CAGR (ann.)
-39.7%
1Y CAGR (ann.)
-65.4%
5Y CAGR (ann.)
-71.0%
All-Time CAGR
-29.4%

Valuation

PE Ratio
-0.00
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.03
PS Ratio
0.00
Forward PS
N/A
PB Ratio
0.00
P/FCF Ratio
-0.00
P/Adj. FCF Ratio
-0.00
P/OCF Ratio
-23.00
EV/Sales
-0.17
EV/EBIT
53,140.68
EV/EBITDA
0.11
EV/FCF
1.78
Earnings Yield
-5215095.7%
FCF Yield
-313617.5%
Adj. FCF Yield
-313617.5%

Financial Health

Net Cash
$156.51B
Total Debt
$148.36B
Cash & Short-Term Investments
$304.87B
Total Assets
$44.71T
Current Ratio
0.26
Quick Ratio
0.08
Debt / Equity Ratio
0.10
Debt / EBITDA
-0.10
Debt / FCF
-1.68
OCF / Debt
-0.59
Interest Coverage
-44.20
Altman Z-Score
-1.54
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
-9.3%
Operating Profit Margin
-151.0%
EBITDA Margin
-36.8%
Net Profit Margin
-114.3%
FCF Margin
-9.3%
Adj. FCF Margin
-9.3%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-10.0%
Return on Equity
-17.1%
Return on Invested Capital
-10.8%
Return on Capital Employed
-11.8%
Return on Tangible Assets
-70.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
4823.7%
Revenue CAGR 5Y
887.4%
Revenue CAGR 10Y
199.8%
EPS CAGR 3Y
-150.0%
EPS CAGR 5Y
-100.0%
EPS CAGR 10Y
-54.5%
FCF CAGR 3Y
-150.0%
FCF CAGR 5Y
-100.0%
FCF CAGR 10Y
-54.5%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 13, 2026
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-88.12B
Free Cash Flow
$-88.12B
Adj. Free Cash Flow
$-88.12B
FCF Per Share
-$0.05
OCF Per Share
-$0.03
OCF/S Ratio
-3.6%

Income Statement

Revenue
$948.34B
Gross Profit
$83.57B
Operating Income
$-1.43T
EBITDA
$-1.43T
Net Income
$-1.46T
EPS (Diluted)
-$35,984
Revenue / Employee
$4.41B
Profit / Employee
$-6.78B
Employees
215

© 2026 bestshares.com. All rights reserved.